Cargando…

Therapeutic effects of bone marrow-derived mononuclear cells from healthy or silicotic donors on recipient silicosis mice

BACKGROUND: Administration of bone marrow mononuclear cells (BMMCs) modulates lung inflammation and fibrosis in experimental silicosis. However, no studies have evaluated whether silicosis affects the efficacy of autologous BMMCs treatment. We hypothesized that BMMCs obtained from healthy or silicot...

Descripción completa

Detalles Bibliográficos
Autores principales: de Oliveira, Helena D’Anunciação, de Melo, Elga Bernardo Bandeira, Silva, Johnatas Dutra, Kitoko, Jamil Zola, Gutfilen, Bianca, Barboza, Thiago, de Souza, Sergio Augusto Lopes, Takiya, Christina Maeda, Rocco, Patricia Rieken Macedo, Lopes-Pacheco, Miquéias, Morales, Marcelo Marcos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5681761/
https://www.ncbi.nlm.nih.gov/pubmed/29126438
http://dx.doi.org/10.1186/s13287-017-0699-7
_version_ 1783277974359900160
author de Oliveira, Helena D’Anunciação
de Melo, Elga Bernardo Bandeira
Silva, Johnatas Dutra
Kitoko, Jamil Zola
Gutfilen, Bianca
Barboza, Thiago
de Souza, Sergio Augusto Lopes
Takiya, Christina Maeda
Rocco, Patricia Rieken Macedo
Lopes-Pacheco, Miquéias
Morales, Marcelo Marcos
author_facet de Oliveira, Helena D’Anunciação
de Melo, Elga Bernardo Bandeira
Silva, Johnatas Dutra
Kitoko, Jamil Zola
Gutfilen, Bianca
Barboza, Thiago
de Souza, Sergio Augusto Lopes
Takiya, Christina Maeda
Rocco, Patricia Rieken Macedo
Lopes-Pacheco, Miquéias
Morales, Marcelo Marcos
author_sort de Oliveira, Helena D’Anunciação
collection PubMed
description BACKGROUND: Administration of bone marrow mononuclear cells (BMMCs) modulates lung inflammation and fibrosis in experimental silicosis. However, no studies have evaluated whether silicosis affects the efficacy of autologous BMMCs treatment. We hypothesized that BMMCs obtained from healthy or silicotic mice may improve lung function, but they might affect the inflammatory and fibrotic processes differently in experimental silicosis. METHODS: C57BL/6 mice were randomly divided into control (C) and silicosis (SIL) groups. Mice in the SIL group were instilled with silica particles intratracheally; the C animals received saline using the same protocol. On day 15, the animals were treated with saline (Sal) or BMMCs (2 × 10(6) cells) from healthy (BMMC-healthy) and silicotic (BMMC-sil) donors. Lung mechanics were measured, and lungs were collected for histology and molecular biology analysis. RESULTS: BMMCs obtained from healthy and silicotic donors presented similar percentages of cell populations. (99m)Tc-BMMCs tracking revealed preferential migration of cells to the liver, and only a few GFP(+) BMMCs were observed in lung tissue 24 h after treatment, regardless of donor type. Both the SIL-BMMC-healthy and SIL-BMMC-sil groups showed improvement in lung function, a reduction in the fractional area of granuloma, and a decrease in the number of mononuclear and apoptotic cells in lung parenchyma. In addition, the number of F4/80(+) macrophages, the levels of interleukin-1 beta and transforming growth factor beta, and collagen fiber content in granuloma were reduced in SIL-BMMC-healthy mice, whereas mRNA expression of MMP-9 and procollagen I and III was reduced in the SIL-BMMC-sil group. CONCLUSIONS: Administration of BMMCs from healthy and silicotic donors reduced lung inflammation and fibrosis, thus improving lung function. In addition, BMMC-healthy exhibited a greater improvement in lung morpho-functional changes in murine model of silicosis.
format Online
Article
Text
id pubmed-5681761
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-56817612017-11-17 Therapeutic effects of bone marrow-derived mononuclear cells from healthy or silicotic donors on recipient silicosis mice de Oliveira, Helena D’Anunciação de Melo, Elga Bernardo Bandeira Silva, Johnatas Dutra Kitoko, Jamil Zola Gutfilen, Bianca Barboza, Thiago de Souza, Sergio Augusto Lopes Takiya, Christina Maeda Rocco, Patricia Rieken Macedo Lopes-Pacheco, Miquéias Morales, Marcelo Marcos Stem Cell Res Ther Research BACKGROUND: Administration of bone marrow mononuclear cells (BMMCs) modulates lung inflammation and fibrosis in experimental silicosis. However, no studies have evaluated whether silicosis affects the efficacy of autologous BMMCs treatment. We hypothesized that BMMCs obtained from healthy or silicotic mice may improve lung function, but they might affect the inflammatory and fibrotic processes differently in experimental silicosis. METHODS: C57BL/6 mice were randomly divided into control (C) and silicosis (SIL) groups. Mice in the SIL group were instilled with silica particles intratracheally; the C animals received saline using the same protocol. On day 15, the animals were treated with saline (Sal) or BMMCs (2 × 10(6) cells) from healthy (BMMC-healthy) and silicotic (BMMC-sil) donors. Lung mechanics were measured, and lungs were collected for histology and molecular biology analysis. RESULTS: BMMCs obtained from healthy and silicotic donors presented similar percentages of cell populations. (99m)Tc-BMMCs tracking revealed preferential migration of cells to the liver, and only a few GFP(+) BMMCs were observed in lung tissue 24 h after treatment, regardless of donor type. Both the SIL-BMMC-healthy and SIL-BMMC-sil groups showed improvement in lung function, a reduction in the fractional area of granuloma, and a decrease in the number of mononuclear and apoptotic cells in lung parenchyma. In addition, the number of F4/80(+) macrophages, the levels of interleukin-1 beta and transforming growth factor beta, and collagen fiber content in granuloma were reduced in SIL-BMMC-healthy mice, whereas mRNA expression of MMP-9 and procollagen I and III was reduced in the SIL-BMMC-sil group. CONCLUSIONS: Administration of BMMCs from healthy and silicotic donors reduced lung inflammation and fibrosis, thus improving lung function. In addition, BMMC-healthy exhibited a greater improvement in lung morpho-functional changes in murine model of silicosis. BioMed Central 2017-11-10 /pmc/articles/PMC5681761/ /pubmed/29126438 http://dx.doi.org/10.1186/s13287-017-0699-7 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
de Oliveira, Helena D’Anunciação
de Melo, Elga Bernardo Bandeira
Silva, Johnatas Dutra
Kitoko, Jamil Zola
Gutfilen, Bianca
Barboza, Thiago
de Souza, Sergio Augusto Lopes
Takiya, Christina Maeda
Rocco, Patricia Rieken Macedo
Lopes-Pacheco, Miquéias
Morales, Marcelo Marcos
Therapeutic effects of bone marrow-derived mononuclear cells from healthy or silicotic donors on recipient silicosis mice
title Therapeutic effects of bone marrow-derived mononuclear cells from healthy or silicotic donors on recipient silicosis mice
title_full Therapeutic effects of bone marrow-derived mononuclear cells from healthy or silicotic donors on recipient silicosis mice
title_fullStr Therapeutic effects of bone marrow-derived mononuclear cells from healthy or silicotic donors on recipient silicosis mice
title_full_unstemmed Therapeutic effects of bone marrow-derived mononuclear cells from healthy or silicotic donors on recipient silicosis mice
title_short Therapeutic effects of bone marrow-derived mononuclear cells from healthy or silicotic donors on recipient silicosis mice
title_sort therapeutic effects of bone marrow-derived mononuclear cells from healthy or silicotic donors on recipient silicosis mice
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5681761/
https://www.ncbi.nlm.nih.gov/pubmed/29126438
http://dx.doi.org/10.1186/s13287-017-0699-7
work_keys_str_mv AT deoliveirahelenadanunciacao therapeuticeffectsofbonemarrowderivedmononuclearcellsfromhealthyorsilicoticdonorsonrecipientsilicosismice
AT demeloelgabernardobandeira therapeuticeffectsofbonemarrowderivedmononuclearcellsfromhealthyorsilicoticdonorsonrecipientsilicosismice
AT silvajohnatasdutra therapeuticeffectsofbonemarrowderivedmononuclearcellsfromhealthyorsilicoticdonorsonrecipientsilicosismice
AT kitokojamilzola therapeuticeffectsofbonemarrowderivedmononuclearcellsfromhealthyorsilicoticdonorsonrecipientsilicosismice
AT gutfilenbianca therapeuticeffectsofbonemarrowderivedmononuclearcellsfromhealthyorsilicoticdonorsonrecipientsilicosismice
AT barbozathiago therapeuticeffectsofbonemarrowderivedmononuclearcellsfromhealthyorsilicoticdonorsonrecipientsilicosismice
AT desouzasergioaugustolopes therapeuticeffectsofbonemarrowderivedmononuclearcellsfromhealthyorsilicoticdonorsonrecipientsilicosismice
AT takiyachristinamaeda therapeuticeffectsofbonemarrowderivedmononuclearcellsfromhealthyorsilicoticdonorsonrecipientsilicosismice
AT roccopatriciariekenmacedo therapeuticeffectsofbonemarrowderivedmononuclearcellsfromhealthyorsilicoticdonorsonrecipientsilicosismice
AT lopespachecomiqueias therapeuticeffectsofbonemarrowderivedmononuclearcellsfromhealthyorsilicoticdonorsonrecipientsilicosismice
AT moralesmarcelomarcos therapeuticeffectsofbonemarrowderivedmononuclearcellsfromhealthyorsilicoticdonorsonrecipientsilicosismice